Evidence map›Paper›PMID 39633156›Full record

ArticleSkeletal radiology2025

Myopericytoma of the hand.

Patrick S Sullivan, Lily M Belfi, Roberto A Garcia, Duretti T Fufa, Roger J Bartolotta

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Skeletal radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Patrick S SullivanBoston Medical Center, One Boston Medical Center Place, Boston, MA, 02118, USA.
Lily M BelfiWeill Cornell Medical College, 1300 York Avenue, New York, NY, 10021, USA.
Roberto A GarciaWeill Cornell Medical College, 1300 York Avenue, New York, NY, 10021, USA.
Duretti T FufaWeill Cornell Medical College, 1300 York Avenue, New York, NY, 10021, USA.
Roger J BartolottaWeill Cornell Medical College, 1300 York Avenue, New York, NY, 10021, USA. rob9074@med.cornell.edu.ORCID http://orcid.org/0000-0001-9365-8773

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myopericytoma is a rare benign smooth-muscle cell neoplasm of the subcutaneous soft tissues that is primarily found in young adults with a male predominance. We present the clinical, radiologic, and histopathologic features of a longstanding myopericytoma of the hand. We emphasize the features that help the radiologist and pathologist to accurately characterize this entity. Radiologic evaluation, particularly MRI, plays a crucial role in differentiating myopericytoma from other soft tissue masses. Characteristic MR features include a well-demarcated lesion with intense post-contrast enhancement, isointensity to muscle on T1-weighted imaging, and hyperintensity on T2-weighted imaging, often with a central vascular pedicle. Histopathologic examination reveals a concentric perivascular growth pattern, which helps to distinguish myopericytoma from other soft tissue tumors. Immunohistochemically, these myoid cell neoplasms stain positive for alpha-smooth muscle actin and h-caldesmon, lack nuclear atypia, and are not highly proliferative (relatively low Ki-67 index and very low mitotic activity). The vast majority stain negative for desmin and CD34. Treatment typically involves complete surgical resection, with excellent prognosis and rare recurrence. Despite its rarity, awareness of this entity is important for clinicians who encounter soft tissue masses of the extremities.

Indexed as

HandMagnetic Resonance ImagingMyopericytomaSoft Tissue NeoplasmsDiagnosis, DifferentialHumansHistopathologyMassMRIMyopericytomaSubcutaneous

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.